(Q35322578)

7 August 2017

Expectant management of prostate cancer with curative intent: an update of the Johns Hopkins experience (English)

1 reference

7 August 2017

1 reference

6

Patrick C Walsh

1 reference

7 August 2017

1

H Ballentine Carter

1 reference

7 August 2017

5

Patricia Landis

1 reference

7 August 2017

7

Jonathan I Epstein

1 reference

7 August 2017

Anna Kettermann

2

1 reference

7 August 2017

Christopher Warlick

series ordinal

3

1 reference

7 August 2017

E Jeffrey Metter

series ordinal

4

1 reference

7 August 2017

language of work or name

English

0 references

publication date

22 October 2007

1 reference

7 August 2017

1 reference

7 August 2017

178

1 reference

7 August 2017

2359-64; discussion 2364-5

1 reference

7 August 2017

6

1 reference

Prognostic markers under watchful waiting and radical prostatectomy

7 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4390051

Delayed versus immediate surgical intervention and prostate cancer outcome

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4390051

Active surveillance for prostate cancer: for whom?

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4390051

The changing face of prostate cancer

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4390051

An analysis of men with clinically localized prostate cancer who deferred definitive therapy

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4390051

Delayed therapy with curative intent in a contemporary prostate cancer watchful-waiting cohort

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4390051

Expectant management of nonpalpable prostate cancer with curative intent: preliminary results

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4390051

Lead times and overdetection due to prostate-specific antigen screening: estimates from the European Randomized Study of Screening for Prostate Cancer.

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4390051

Survival associated with treatment vs observation of localized prostate cancer in elderly men

26 September 2018

1 reference

12 December 2020

Pathologic and clinical findings to predict tumor extent of nonpalpable (stage T1c) prostate cancer

1 reference

12 December 2020

Active surveillance for prostate cancers detected in three subsequent rounds of a screening trial: characteristics, PSA doubling times, and outcome

1 reference

12 December 2020

Temporarily deferred therapy (watchful waiting) for men younger than 70 years and with low-risk localized prostate cancer in the prostate-specific antigen era

1 reference

12 December 2020

Validation of a prediction model for low volume/low grade cancer: application in selecting patients for active surveillance

1 reference

12 December 2020

Counseling Men With Prostate Cancer: A Nomogram for Predicting the Presence of Small, Moderately Differentiated, Confined Tumors

1 reference

12 December 2020

PSA doubling time predicts the outcome after active surveillance in screening-detected prostate cancer: Results from the European randomized study of screening for prostate cancer, Sweden section

1 reference

12 December 2020

10.1016/J.JURO.2007.08.039

Identifiers

DOI

1 reference

7 August 2017

1 reference

7 August 2017

1 reference